» Articles » PMID: 86304

Bleomycin-induced Pulmonary Fibrosis in the Rat: Inhibition by Indomethacin

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 1979 Apr 1
PMID 86304
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

A model for pulmonary fibrosis in the rat has been developed using intratracheal administration of bleomycin. The histopathologic features of the reaction are similar to those reported in the hamster model. Increases in vascular permeability are seen in the lung within 24 hours and persist over a 2-month period. Extractable collagen, as measured by hydroxyproline, increases during this time by a factor greater than 1.5 times the reference control values of normal lung. During this same period, a prominent eosinophilia develops. The continued treatment of bleomycin-injected rats with indomethacin markedly diminishes the amount of extractable lung collagen at 60 days and the histopathologic evidence of pulmonary fibrosis. The eosinophilia over the first 3 weeks is also markedly suppressed. Less dramatic effects were seen with the permeability changes. These findings indicate that the rat is a reliable and useful model for the study of blemoycin-induced pulmonary fibrosis and that treatment with indomethacin ameliorates the lung changes.

Citing Articles

HMGB1 Box A gene therapy to alleviate bleomycin-induced pulmonary fibrosis in rats.

Patarat R, Chuaybudda S, Yasom S, Mutirangura A BMC Pulm Med. 2025; 25(1):52.

PMID: 39891078 PMC: 11786397. DOI: 10.1186/s12890-025-03522-2.


Cromolyn sodium and masitinib combination inhibits fibroblast-myofibroblast transition and exerts additive cell-protective and antioxidant effects on a bleomycin-induced in vitro fibrosis model.

Goksu A, Dirol H, Kocanci F Pharmacol Res Perspect. 2024; 12(5):e70018.

PMID: 39360479 PMC: 11447456. DOI: 10.1002/prp2.70018.


Transcriptomic characterization of lung pericytes in systemic sclerosis-associated pulmonary fibrosis.

Renaud L, Wilson C, Lafyatis R, Schnapp L, Feghali-Bostwick C iScience. 2024; 27(6):110010.

PMID: 38868196 PMC: 11167435. DOI: 10.1016/j.isci.2024.110010.


Induction of lung lesions by bronchial administration using bronchoscope technique in mice.

Hiyoshi T, Nishime C, Nishinaka E, Seki F, Kawai K, Mochizuki M J Toxicol Pathol. 2024; 37(2):93-97.

PMID: 38584970 PMC: 10995434. DOI: 10.1293/tox.2023-0123.


Animal models of acute exacerbation of pulmonary fibrosis.

Ye X, Zhang M, Gu H, Liu M, Zhao Y, Shi Y Respir Res. 2023; 24(1):296.

PMID: 38007420 PMC: 10675932. DOI: 10.1186/s12931-023-02595-z.


References
1.
OLINER H, Schwartz R, Rubio F, DAMESHEK W . Interstitial pulmonary fibrosis following busulfan therapy. Am J Med. 1961; 31:134-9. DOI: 10.1016/0002-9343(61)90229-7. View

2.
Woessner Jr J . The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys. 1961; 93:440-7. DOI: 10.1016/0003-9861(61)90291-0. View

3.
SPEIRS R . The principles of eosinophil diluents. Blood. 1952; 7(5):550-4. View

4.
Wahl L, Olsen C, Sandberg A, Mergenhagen S . Prostaglandin regulation of macrophage collagenase production. Proc Natl Acad Sci U S A. 1977; 74(11):4955-8. PMC: 432076. DOI: 10.1073/pnas.74.11.4955. View

5.
Ko S, Page R, Narayanan A . Fibroblast heterogeneity and prostaglandin regulation of subpopulations. Proc Natl Acad Sci U S A. 1977; 74(8):3429-32. PMC: 431592. DOI: 10.1073/pnas.74.8.3429. View